REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Baltfarmacevtika OOO (Russia)

Main Activities: Lessors of Real Estate
Full name: Baltfarmacevtika OOO Profile Updated: September 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Russian Download a sample report

Baltfarmacevtika OOO is based in Russia. The head office is in Bagrationovsk. It operates in the Lessors of Real Estate sector. It was incorporated on December 16, 2002. Baltfarmacevtika OOO currently employs 51 (2022) people. From the latest financial highlights, Baltfarmacevtika OOO reported a net sales revenue drop of 10.11% in 2023. Its’ total assets recorded a growth of 0.51%. Baltfarmacevtika OOO’s net profit margin decreased by 24.52% in 2023.

Headquarters
Kommunalinaya, 2
Bagrationovsk; Kaliningrad Oblast; Postal Code: 238420

Contact Details: Purchase the Baltfarmacevtika OOO report to view the information.

Website: http://baltfarm.ru

Basic Information
Total Employees:
Purchase the Baltfarmacevtika OOO report to view the information.
Outstanding Shares:
Purchase the Baltfarmacevtika OOO report to view the information.
Registered Capital:
Purchase the Baltfarmacevtika OOO report to view the information.
Incorporation Date:
December 16, 2002
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
85%
Purchase this report to view the information.
15%
Company Performance
Financial values in the chart are available after Baltfarmacevtika OOO report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
-10.11%▼
Total operating revenue
-10.11%▼
Operating profit (EBIT)
-69.71%▼
Net Profit (Loss) for the Period
-89.09%▼
Total assets
0.51%▲
Total equity
1%▲
Operating Profit Margin (ROS)
-10.52%▼
Net Profit Margin
-24.52%▼
Return on Equity (ROE)
-8.2%▼
Quick Ratio
3.6%▲
Cash Ratio
3.33%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo